Biomarkers for acute diagnosis and management of stroke in neurointensive care units

THERAPEUTIC CLASS

Biomarkers for acute diagnosis and management of stroke in neurointensive care units

Glushakova OY - Personal Name;

The effectiveness of current management of critically ill stroke patients depends on rapid assessment of the type of stroke, ischemic or hemorrhagic, and on a patient’s general clinical status. Thrombolytic therapy with recombinant tissue plasminogen activator (r-tPA) is the only effective treatment for ischemic stroke approved by the Food and Drug Administration (FDA), whereas no treatment has been shown to be effective for hemorrhagic stroke.

Availability

Location name is not set Location name is not set

REQJ4579

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Cardiovascular & Hematopoeiteic System
Specific Detail Info: Brain Circ 2016;2:28-47
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment